| Terminated | An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopa Uterine Fibroids | Phase 2 | 2016-07-26 |
| Completed | A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition Acquired Hypogonadotropic Hypogonadism, Obesity | Phase 2 | 2016-01-11 |
| Completed | A Multi-Center, Parallel Design, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of 6 and 1 Uterine Fibroids | Phase 2 | 2015-03-16 |
| Completed | Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fi Uterine Fibroids | Phase 2 | 2015-02-12 |
| Completed | An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolab Secondary Hypogonadism | Phase 1 | 2014-12-01 |
| Completed | An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal Pharmacokinetics | Phase 1 | 2014-08-01 |
| Completed | Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal Normal Volunteers | Phase 1 | 2014-06-01 |
| Completed | Assessment of Drug-Drug Interactions of Androxal With Cytochrome P450 Isoenyzmes in Healthy Males Drug-drug Interaction | Phase 1 | 2014-05-01 |
| Completed | Comparison of Two Formulations of Proellex for Oral Administration Healthy | Phase 1 | 2014-05-01 |
| Completed | A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects Healthy | Phase 1 | 2014-04-01 |
| Completed | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotr Secondary Hypogonadism | Phase 3 | 2014-01-01 |
| Completed | A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotr Secondary Hypogonadism | Phase 3 | 2014-01-01 |
| Completed | Comparison of Two Formulations of Androxal Bioequivalence | Phase 1 | 2013-12-31 |
| Withdrawn | Open-Label Extension Study to ZPE-202 Endometriosis | Phase 2 | 2013-12-01 |
| Completed | Comparison of Two Formulations of Proellex for Vaginal Administration Comparison of 2 Different Formulations of 12 mg Proellex Vaginal Capsules | Phase 1 | 2013-10-01 |
| Completed | A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal Pharmacokinetics, Tolerability | Phase 1 | 2013-10-01 |
| Completed | Evaluation of the Pharmacokinetics and Safety of Androxal in Male Subjects With Impaired Hepatic Function Secondary Hypogonadism | Phase 1 | 2013-08-01 |
| Completed | Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function Secondary Hypogonadism | Phase 1 | 2013-08-01 |
| Completed | Safety and Efficacy of Telapristone Acetate (Proellex®) in the Treatment of Pre-Menopausal Women With Confirme Endometriosis | Phase 2 | 2013-05-02 |
| Completed | Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 3 | 2012-11-01 |
| Completed | An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 3 | 2012-11-01 |
| Completed | Extension of Study ZPV-200 Uterine Fibroids | Phase 2 | 2012-09-01 |
| Completed | Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism Effect of Treatment on Bone Mineral Density | Phase 3 | 2012-09-01 |
| Completed | Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatm Uterine Fibroids | Phase 2 | 2012-09-01 |
| Completed | Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 3 | 2012-08-01 |
| Completed | Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 3 | 2012-05-01 |
| Completed | Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Uterine Fibroids | Phase 2 | 2012-02-01 |
| Completed | A One Year Open Label Study for the Treatment of Hypogonadism (Low Testosterone) in Men Who Have Completed ZA- Hypogonadism, Low Testosterone | Phase 2 | 2011-07-01 |
| Completed | The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testost Secondary Hypogonadism | Phase 2 | 2011-06-01 |
| Completed | Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 2 | 2011-01-01 |
| Completed | Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus Type 2 Diabetes Mellitus, Secondary Hypogonadism | Phase 2 | 2010-10-01 |
| Completed | Determination of the Lowest, Safe and Effective Dose of Proellex Amenorrhea | Phase 1 / Phase 2 | 2010-08-01 |
| Terminated | Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids Uterine Fibroids | Phase 3 | 2009-04-01 |
| Completed | Investigate Absorption, Metabolism and Excretion of [14C}-Proellex Following Single Oral Dose in Healthy Femal ABSORPTION, METABOLISM, EXCRETION | Phase 1 | 2009-04-01 |
| Terminated | Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study Endometriosis | Phase 2 | 2009-02-28 |
| Terminated | Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids Uterine Fibroids | Phase 3 | 2009-02-01 |
| Terminated | Study to Evaluate Menses Induction in Women Administered Proellex Amenorrhea | Phase 1 | 2009-02-01 |
| Terminated | Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Fema Renal Impairment | Phase 1 / Phase 2 | 2008-10-01 |
| Terminated | Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids Uterine Fibroids, Anemia | Phase 3 | 2008-10-01 |
| Terminated | Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids Uterine Fibroids | Phase 3 | 2008-10-01 |
| Completed | Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults Impaired Liver Function | Phase 1 | 2008-10-01 |
| Completed | Crossover Study of the Safety and PK Properties of Proellex® Pharmacokinetics | Phase 1 | 2008-08-11 |
| Terminated | Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fib Uterine Fibroids | Phase 3 | 2008-08-01 |
| Completed | Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjec Drug Interactions | Phase 1 | 2008-07-01 |
| Terminated | An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Uterine Fibroids | Phase 2 | 2008-06-01 |
| Terminated | Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids Uterine Fibroids, Anemia | Phase 3 | 2008-06-01 |
| Completed | To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone Secondary Hypogonadism | Phase 2 | 2008-06-01 |
| Terminated | Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibro Uterine Fibroids | Phase 2 | 2008-05-01 |
| Completed | Proellex® Pharmacokinetic Bridging Study II Healthy | Phase 1 | 2008-02-29 |
| Completed | A Safety and Pharmacokinetic Study of Proellex® Healthy | Phase 1 | 2008-02-01 |
| Terminated | Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endome Endometriosis | Phase 2 | 2007-11-01 |
| Completed | Proellex Pharmacokinetics Bridging Study Healthy | Phase 1 | 2007-06-01 |
| Completed | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 Uterine Fibroids | Phase 2 | 2006-09-07 |
| Completed | Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 3 | 2006-03-01 |
| Completed | Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids Uterine Fibroids | Phase 2 | 2006-03-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism Secondary Hypogonadism | Phase 3 | 2006-03-01 |
| Completed | A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata Uterine Leiomyomata | Phase 1 / Phase 2 | 2004-07-01 |
| Withdrawn | Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms Uterine Fibroids | Phase 3 | — |